Repository logo
 

Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells.

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

Autophagy is central to the benefits of longevity signaling programs and to hematopoietic stem cell (HSC) response to nutrient stress. With age, a subset of HSCs increases autophagy flux and preserves regenerative capacity, but the signals triggering autophagy and maintaining the functionality of autophagy-activated old HSCs (oHSCs) remain unknown. Here, we demonstrate that autophagy is an adaptive cytoprotective response to chronic inflammation in the aging murine bone marrow (BM) niche. We find that inflammation impairs glucose uptake and suppresses glycolysis in oHSCs through Socs3-mediated inhibition of AKT/FoxO-dependent signaling, with inflammation-mediated autophagy engagement preserving functional quiescence by enabling metabolic adaptation to glycolytic impairment. Moreover, we show that transient autophagy induction via a short-term fasting/refeeding paradigm normalizes glycolytic flux and significantly boosts oHSC regenerative potential. Our results identify inflammation-driven glucose hypometabolism as a key driver of HSC dysfunction with age and establish autophagy as a targetable node to reset oHSC regenerative capacity.

Description

Journal Title

Cell Stem Cell

Conference Name

Journal ISSN

1934-5909
1875-9777

Volume Title

Publisher

Elsevier

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Wellcome Trust (206328/Z/17/Z)
Wellcome Trust (203151/Z/16/Z)
Wellcome Trust (203151/A/16/Z)
Cancer Research UK (21762)
Medical Research Council (MC_PC_17230)
We thank Drs. S. Sebti and B. Levine (UT Southwestern) for shipping bones from Becn1KI mice, O. Olson (CUIMC) for help with Seahorse assays, D. Ho (Stanford) for assistance with CyTOF sample processing, M. Martin-Sandoval and T. Mathews (UT Southwestern) for help generating metabolomic data, M. Kissner for management of the CSCI Flow Cytometry Core facilities, and all members of the Passegué laboratory for critical insights and suggestions. P.V.D was supported by NIH F31HL151140, M.A.P. by NIH TL1DK136048, C.A.M by NIHF31 HL160207, J.W.S. by EMBO ALTF-2021-196 and Damon Runyon Cancer Research Foundation DRG-2493-23 postdoctoral fellowships, and T.T.H. by an AHA and Hillblom Center for the Biology of Aging predoctoral fellowships. F.J.C-N., X.W. and B.G. were supported by grants from the Wellcome (206328/Z/17/Z), CRUK (C1163/A21762) and core funding by the Wellcome to the Cambridge Stem Cell Institute. This work was funded by NIH R01AG073599, NIH R35HL135763, Glenn Foundation Research Award, LLS Scholar Award, and Milky Way Research Foundation Award CU21-0225 to E.P., and supported in part through the NIH/NCI Cancer Center Support Grant P30CA013696 to CUIMC.

Relationships

Is derived from: